Xiaoyun Wan
Overview
Explore the profile of Xiaoyun Wan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shen Y, Tang S, Zhou Y, Zhang Q, Chen T, Li J, et al.
J Low Genit Tract Dis
. 2024 Dec;
29(1):60-67.
PMID: 39620892
Objective: The aim of the study was to investigate the distribution and association between human papillomavirus (HPV) genotypes and integration as well as their correlation with cervical lesions. Methods: Two...
2.
Han X, Qian X, Wan X, Chen Y, Chen L
Arch Gynecol Obstet
. 2024 Aug;
310(4):2161-2166.
PMID: 39210069
Purpose: This study was presented to investigate the clinical-pathological characteristics of gestational trophoblastic neoplasia (GTN) following non-molar pregnancy and differentiated with ectopic pregnancy (EP). Methods: The clinical data of 83...
3.
Wang H, Wan X, Li F, He X, Xu G, Xu C, et al.
ACS Nano
. 2024 Jul;
18(26):16867-16877.
PMID: 38952328
Suppressing Sn oxidation and rationally controlling the crystallization process of tin-lead perovskite (Sn-Pb PVK) films by suitable bonding methods have emerged as key approaches to achieving efficient and stable Sn-Pb...
4.
Wan X, Xu C, Wang H, Jiang Z, Li F, Xu G, et al.
Small
. 2024 Mar;
20(32):e2401136.
PMID: 38501858
High quality tin-lead perovskite solar cells (Sn─Pb PSCs) can be fabricated via simple solution processing methods. However, the instability of precursor solutions and their narrow usage windows still pose challenges...
5.
Liu J, Wang Y, Wan X, Zou J, Zhu Y, Lv W, et al.
J Gynecol Oncol
. 2022 Nov;
34(1):e8.
PMID: 36424703
Objective: To compare the safety between cervical conization (CC) alone and hysterectomy for patients with adenocarcinoma in situ (AIS) of the cervix. Methods: Patients diagnosed with AIS after CC during...
6.
Weng D, Xiong H, Zhu C, Wan X, Chen Y, Wang X, et al.
Front Med
. 2022 Nov;
17(1):93-104.
PMID: 36422763
We conducted a prospective study to assess the non-inferiority of adjuvant chemotherapy alone versus adjuvant concurrent chemoradiotherapy (CCRT) as an alternative strategy for patients with early-stage (FIGO 2009 stage IB-IIA)...
7.
Li N, Zhang Y, Wang J, Zhu J, Wang L, Wu X, et al.
J Clin Oncol
. 2022 Apr;
40(22):2436-2446.
PMID: 35404684
Purpose: This phase III trial aimed to explore the efficacy and safety of fuzuloparib (formerly fluzoparib) versus placebo as a maintenance treatment after response to second- or later-line platinum-based chemotherapy...
8.
Chen L, Niu Y, Wan X, Yu L, Zhang X, Strickland A, et al.
BMC Cancer
. 2021 Oct;
21(1):1095.
PMID: 34635081
Background: We aimed to analyze the clinicopathological features and outcomes of patients with gastric-type of HPV-independent endocervical adenocarcinoma (GAS HPVI ECA), and compare them with non-GAS HPVI ECA cases. Methods:...
9.
Chen L, Xi L, Jiang J, Yin R, Qu P, Li X, et al.
Front Med
. 2021 Jun;
16(2):276-284.
PMID: 34181195
We aimed to evaluate the effectiveness and safety of single-course initial regimens in patients with low-risk gestational trophoblastic neoplasia (GTN). In this trial (NCT01823315), 276 patients were analyzed. Patients were...
10.
Cai L, Wan X, Hsu H, Ran J, Meng X, Luo Z, et al.
Sci Rep
. 2021 Feb;
11(1):3581.
PMID: 33574343
Due to the independence of the gradiometer instrument's orientation in space, the second invariant [Formula: see text] of gravity gradients in combination with individual gravity gradients are demonstrated to be...